Plasma oncotic pressure regulation

Plasma oncotic pressure regulation refers to the physiological control of the osmotic force exerted by plasma proteins—primarily albumin—within blood vessels. This force is crucial for maintaining fluid balance between the vascular and interstitial compartments. Albumin is responsible for approximately 70–80% of total plasma oncotic pressure due to its abundance and molecular properties, while globulins and fibrinogen contribute less significantly. The normal value for capillary plasma oncotic pressure is about 25–30 mmHg, compared with much lower values in interstitial fluid. The main biological functions include retaining water within the vasculature, preventing excessive fluid leakage into tissues, supporting lymphatic return, and ensuring effective capillary exchange necessary for oxygen delivery. Disruption in this regulatory mechanism—most often due to decreased synthesis or increased loss of albumin—can result in pathological states such as edema or ascites. This entry does not represent a discrete therapeutic target like an enzyme or receptor but rather describes an emergent property resulting from multiple underlying molecules and processes. Therefore, it should not be classified as a druggable target per se. Instead, interventions such as intravenous albumin administration aim to restore normal plasma oncotic pressures indirectly by supplementing key proteins that generate this force.[1][3][5]

Other names

Colloid osmotic pressure regulationBlood colloidal osmotic pressure regulationRegulation of plasma oncotic pressure